Position in INSM
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$43,542,326
-$22,012,839 QoQ
Shares Held
408,388
+1.9% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#88
of 665 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 76%
Shared 15%
None 9%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. INSM ranks #35 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in INSM
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,542,326 | 408,388 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $65,555,165 | 400,900 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $69,454,663 | 399,073 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $55,684,488 | 386,671 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $41,437,914 | 411,744 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $28,379,877 | 372,000 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $24,228,827 | 350,939 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $26,809,396 | 367,252 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $809,963 | 12,089 | Shares | Sole | 2024-08-09 | |
| 2023-12-31 | $2,264,532 | 73,073 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,821,004 | 72,119 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,499,408 | 71,062 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,225,434 | 71,873 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,581,237 | 79,141 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,378,273 | 110,412 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,649,203 | 185,051 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $14,671,261 | 624,309 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,147,043 | 409,216 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $3,176,078 | 115,326 | Shares | Defined | 2021-11-12 | |
| 2020-06-30 | $5,671,587 | 205,940 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,360,897 | 272,046 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||